Skip to main content
Home

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Home

Main navigation InfoLep

  • Leprosy [5]
    • Global and Regional Leprosy Situation
    • WHO Global Leprosy Strategy
    • ILEP Strategy
    • World Leprosy Day
    • Leprosy journals
  • Key topics [7]
    • Leprosy and COVID-19
    • Diagnostic tests
    • Prevention of leprosy [2]
      • Interventions to reduce transmission: post-exposure prophylaxis (PEP) [3]
        • LPEP Programme
        • PEP++ project
        • PEP4LEP project
      • Interventions to reduce transmission: vaccines
    • Rehabilitation & prevention of disability [2]
      • Preventing leprosy-related disabilities in girls and boys
      • Self-care in leprosy
    • Leprosy Antibiotic Treatment
    • Stigma, discrimination & mental wellbeing [4]
      • World Leprosy Day 2022
      • Gender
      • Mental wellbeing
      • SARI Project
    • Bioarchaeology of leprosy
  • Toolkits [6]
    • Guides on Stigma and Mental Wellbeing [5]
      • Guide 1. What are health-related stigma and mental wellbeing? [8]
        • 1. What is stigma?
        • 2. Why does stigma exist?
        • 3. What are the causes of stigma?
        • 4. Who stigmatises?
        • 5. How does it feel to experience stigma?
        • 6. What are the effects of stigma?
        • 7. Effects of stigma and discrimination on mental wellbeing
        • Annex Guide 1
      • Guide 2. How to reduce the impact of stigma [7]
        • 1. From undetected disease to diagnosis to support
        • 2. Individual-level interventions
        • 3. Group-level interventions
        • 4. Family-level interventions
        • 5. Referral
        • 6. Further reading
        • Annexes Guide 2
      • Guide 3. How to reduce sources of stigma [6]
        • 1. Background to the design of a stigma-reduction intervention
        • 2. Identifying the sources of stigma
        • 3. Targeting an intervention
        • 4. Inclusion of affected persons and champions in interventions
        • 5. Interventions by source type
        • Annexes Guide 3
      • Guide 4. How to assess health-related stigma and mental wellbeing [9]
        • 1. What is the purpose of the assessment?
        • 2. What approach would best fit your purpose and context?
        • 3. Quantitative assessment methods
        • 4. Qualitative assessment methods
        • 5. Assessments using mixed methods
        • 6. Developing qualitative methods from scratch
        • 7. How do you conduct a stigma assessment?
        • 8. How to interpret and report your findings
        • Annexes Guide 4
      • Glossary
    • NTD Morbidity and Disability Toolkit [15]
      • CHIEF
      • Clinical Profile
      • EMIC affected persons
      • EMIC-CS Community Stigma
      • Participation Scale
      • Patient Health Questionnaire (PHQ-9)
      • 5-Question Stigma Indicators
      • Salsa Scale
      • SARI Stigma Scale
      • SDS Social Distance Scale
      • SRQ Self-reporting Questionnaire
      • Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS)
      • WGQ Washington Group Questions
      • WHODAS
      • WHOQOL-BREF
    • Perception Study Toolkit (PST)
    • Zero Leprosy Toolkit
    • CBM's Community Mental Health Good Practice Guides
    • GPZL & Infolep Factsheets
  • Online courses

Top menu InfoLep

  • About InfoLep
  • News & Events
  • e-learning.infoNTD.org
Visit our e-learning platform
Search resources Search in Practical Materials, Publications, Organizations, Online Course and more
Publication

Stakeholder perspectives on an integrated package of care for lower limb disorders caused by podoconiosis, lymphatic filariasis or leprosy: A qualitative study

Davies B, Kinfe M, Ali O, et al. Public Library of Science (PLoS). PLOS Neglected Tropical Diseases. 2022; 16 (1) : e0010132.
Download PDF
Publication

Standardization of SYBR Green-Based Real-Time PCR Through the Evaluation of Different Thresholds for Different Skin Layers: An Accuracy Study and Track of the Transmission Potential of Multibacillary and Paucibacillary Leprosy Patients.

Sevilha-Santos L, Cerqueira S, Gomes CM. Frontiers in microbiology. 2021;
Download PDF
Publication

Type 2 leprosy reaction presenting as a monoarthritis post multidrug therapy.

Goulart IMB, Santana M, da Costa W, et al. IDCases. 2022;
Download PDF
Publication

Single-lesion paucibacillary leprosy: a retrospective study of 75 cases treated with the ROM scheme.

Pennini SN, França J, Rebello P, et al. Anais brasileiros de dermatologia. 2022;
Download PDF
Publication

Disability in Leprosy: Daily Activities and Social Participation in Indonesia

Solikhah FK. Kamla Raj Enterprises. STUDIES ON ETHNO-MEDICINE. 2021;
Download PDF
Publication

A case-control study to determine the risk factors for disability among the leprosy cases in Andhra Pradesh, India.

Govindarajulu S, Muthuvel T, Lal V, et al. Anais brasileiros de dermatologia. 2022;
Download PDF
Publication

Application of the ARIMA Model to Predict Under-Reporting of New Cases of Hansen's Disease during the COVID-19 Pandemic in a Municipality of the Amazon Region.

da Cunha V, Botelho G, de Oliveira A, et al. International journal of environmental research and public health. 2021;
Download PDF
Publication

The immune-suppressive landscape in lepromatous leprosy revealed by single-cell RNA sequencing.

Mi Z, Wang Z, Xue X, et al. Cell discovery. 2022; 8 (1) : 2.
Download PDF
Publication

Follow-up assessment of patients with Pure Neural Leprosy in a reference center in Rio de Janeiro-Brazil.

Pitta IJR, Hacker M, Andrade L, et al. PLoS neglected tropical diseases. 2022; 16 (1) : e0010070.
Download PDF
Publication

Trigger of Type 2 Lepra reaction with acute foot drop following Covid-19 vaccination.

Panda A, Begum F, Panda M, et al. Journal of the European Academy of Dermatology and Venereology : JEADV. 2022;
Download PDF

Pagination

  • Previous page ‹‹
  • Page 228
  • Next page ››
Subscribe to Full text online

Quick links

  • Leprosy
  • Key topics
  • Toolbox
  • Publications

Support

  • Contact
  • Privacy statement
  • Contact
  • FAQ

Contact us

info@infolep.org

(+31) 20 595 0500

     

Stay up to date with the latest publications and news related to leprosy.

Subscribe to newsletter

Related websites:

  • infontd

© 2025 InfoNTD